For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The power of the pen (or keyboard): Having a say on future health law
The power of the pen (or keyboard): Having a say on future health law

Health has a high profile in Parliament with legislation regarding medicinal cannabis and end-of-life care currently at various stages in the legislative process. The Government’s Misuse of Drugs (Medicinal Cannabis) Amendment Bill has passed its first reading and has gone on to select committee stage. ACT MP David Seymour’s End of Life Choice Bill, which would legalise euthanasia under certain conditions, is also at the select committee stage, with public submissions open until 20 February. Simpson Grierson lawyer Sally McKechnie explains how the legislative process works and how you can provide feedback on, critique or support bills, when submissions are called for
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.